121 results
CORRESP
NKTR
Nektar Therapeutics
9 Nov 21
Correspondence with SEC
12:00am
, SFJ and we have agreed that SFJ will fund up to $150.0 million (the “Funding Commitment”) to conduct a Phase 2/3 study in squamous cell cancer … has been our CRO for our bempegaldesleukin program, as well as other third-party vendors. SFJ’s Funding Commitment also includes quarterly payments
S-3ASR
EX-5.1
NKTR
Nektar Therapeutics
18 Jan 11
Automatic shelf registration
12:00am
to a firm commitment underwritten offering, the underwriting agreement with respect to the Common Stock has been duly authorized, executed … of the nominal owners, and (iii) if the Preferred Stock is to be sold pursuant to a firm commitment underwritten offering, the underwriting agreement
8-K
EX-99.1
NKTR
Nektar Therapeutics
19 Jan 11
Nektar Therapeutics Prices Public Offering of Common Stock
12:00am
announced the pricing of a firm commitment underwritten public offering of 19,000,000 shares of its common stock. The public offering is expected
8-K
NKTR
Nektar Therapeutics
19 Jan 11
Nektar Therapeutics Prices Public Offering of Common Stock
12:00am
Events.
On January 19, 2011, Nektar Therapeutics, a Delaware corporation (“Nektar”), issued a press release announcing the pricing of a firm commitment
8-K
EX-99.1
NKTR
Nektar Therapeutics
20 Dec 07
Entry into a Material Definitive Agreement
12:00am
., Ph.D., Nektar Chief Operating Officer and Head of the PEGylation Business
Unit. "This agreement highlights our commitment to collaborate with market
8-K
EX-3.1
w5qo6i7apwgunaq
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
EX-99.1
hdmd z465
6 Aug 07
Bayer HealthCare and Nektar Therapeutics Launch Global Development and Commercialization Agreement to Fight Gram-Negative Pneumonias
12:00am
8-K
EX-3.1
ule2dv p5n
17 Dec 19
Departure of Directors or Certain Officers
9:12am
8-K
1o0m9igyt z50j5
24 Oct 07
Termination of a Material Definitive Agreement
12:00am
8-K
EX-99.1
uys4f9h69f laq
4 Aug 09
Nektar Therapeutics Reports Second Quarter 2009 Financial Results
12:00am
8-K
fcff54ibryzrsdme21
17 Feb 21
Entry into a Material Definitive Agreement
8:05am
8-K
EX-3.1
utgad
21 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:31pm
8-K
EX-3.1
914iu7z
6 Feb 19
Amendments to Articles of Incorporation or Bylaws
4:12pm
CORRESP
on2cja
7 Dec 18
Correspondence with SEC
12:00am
8-K
EX-1.1
urh4n35gjn5gtdsoar
17 Aug 05
Nektar Announces $24 Million Common Stock Financing
12:00am